Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoma × Trastuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 241 Stomach Neoplasms 23 Breast Neoplasms, Male 16 Neoplasm Metastasis 14 Neoplasms 8 Inflammatory Breast Neoplasms 8 Esophageal Neoplasms 8 Brain Neoplasms 8 Colorectal Neoplasms 6 Adenocarcinoma Of Esophagus 4 Urologic Neoplasms 3 Triple Negative Breast Neoplasms 3 HER2-positive Breast Cancer 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Ductal, Breast 3 Gallbladder Neoplasms 2 Endometrial Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Lobular 2 Carcinoma, Intraductal, Noninfiltrating 2 Biliary Tract Neoplasms 2 Adenocarcinoma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Solid Cancers 1 Rectal Neoplasms 1 Patient Preference 1 Patient Compliance 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Rituximab 171 Cyclophosphamide 154 fludarabine phosphate 71 Vincristine 71 Etoposide 68 Doxorubicin 67 Prednisone 65 Filgrastim 58 Methotrexate 52 Cytarabine 51 fludarabine 49 Melphalan 48 Busulfan 47 Tacrolimus 41 Whole-Body Irradiation 39 Mycophenolic Acid 39 Granulocyte Colony-Stimulating Factor 37 Antilymphocyte Serum 31 Peripheral Blood Stem Cell Transplantation 30 Radiotherapy 27 Lenalidomide 25 Dexamethasone 25 Carmustine 23 Stem Cell Transplantation 22 Cyclosporine 22 Bortezomib 22 Gemcitabine 20 Bendamustine Hydrochloride 20 Alemtuzumab 19 thymoglobulin 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡